Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 21.19% vs 46.53% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 32.20% vs 29.67% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 63.08% vs 1.56% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is 8.33% vs 0.00% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Novelix Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 21.19% vs 46.53% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 23.02% vs 818.18% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 32.20% vs 29.67% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 194.34% vs 307.69% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 63.08% vs 1.56% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 202.86% vs 218.18% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 8.33% vs 0.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025